BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 33983461)

  • 21. Long-term outcome of portomesenteric vein invasion and prognostic factors in pancreas head adenocarcinoma.
    Jeong J; Choi DW; Choi SH; Heo JS; Jang KT
    ANZ J Surg; 2015 Apr; 85(4):264-9. PubMed ID: 24641800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus.
    Shi J; Lai EC; Li N; Guo WX; Xue J; Lau WY; Wu MC; Cheng SQ
    Ann Surg Oncol; 2010 Aug; 17(8):2073-80. PubMed ID: 20131013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of cryopreserved homologous veins for venous reconstruction in pancreatoduodenectomy.
    Yamamoto M; Akamatsu N; Aoki T; Sakamoto Y; Tamura S; Hasegawa K; Kokudo N
    Surgery; 2017 Feb; 161(2):385-393. PubMed ID: 27726914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long term results of pancreatectomy with portal-superior mesenteric vein resection for pancreatic carcinoma: a systematic review.
    Tang D; Zhang JQ; Wang DR
    Hepatogastroenterology; 2011; 58(106):623-31. PubMed ID: 21661443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of venous invasion in resected T3 pancreatic adenocarcinoma: Depth of invasion matters.
    Addeo P; Velten M; Averous G; Faitot F; Nguimpi-Tambou M; Nappo G; Felli E; Fuchshuber P; Bachellier P
    Surgery; 2017 Aug; 162(2):264-274. PubMed ID: 28576385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pancreatic adenocarcinoma with venous involvement: is up-front synchronous portal-superior mesenteric vein resection still justified? A survey of the Association Française de Chirurgie.
    Delpero JR; Boher JM; Sauvanet A; Le Treut YP; Sa-Cunha A; Mabrut JY; Chiche L; Turrini O; Bachellier P; Paye F
    Ann Surg Oncol; 2015; 22(6):1874-83. PubMed ID: 25665947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endoscopic ultrasonography complements computed tomography in predicting portal or superior mesenteric vein resection in patients with borderline resectable pancreatic carcinoma.
    Glazer ES; Rashid OM; Klapman JB; Harris CL; Hodul PJ; Pimiento JM; Malafa MP
    Pancreatology; 2017; 17(1):130-134. PubMed ID: 28043760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of a pancreatectomy with a limited venous resection for pancreatic cancer.
    Illuminati G; Carboni F; Lorusso R; D'Urso A; Ceccanei G; Papaspyropoulos V; Pacile MA; Santoro E
    Surg Today; 2008; 38(6):517-23. PubMed ID: 18516531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benefit of portal or superior mesenteric vein resection with adjuvant chemotherapy for patients with pancreatic head carcinoma.
    Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakashima A; Kondo N; Nakagawa N; Sueda T
    J Surg Oncol; 2013 Mar; 107(4):414-21. PubMed ID: 22886567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction and clinical implications of portal vein/superior mesenteric vein invasion in patients with resected pancreatic head cancer: the significance of preoperative CT parameters.
    Kim M; Kang TW; Cha DI; Kim YK; Kim SH; Jang KT; Han IW; Sohn I
    Clin Radiol; 2018 Jun; 73(6):564-573. PubMed ID: 29519500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The technique of radical pancreaticoduodenectomy for malignant tumor in pancreatic head with pressed superior mesenteric blood vessels or portal vein].
    Qin RY; Zou SQ; Qiu FZ
    Zhonghua Wai Ke Za Zhi; 2008 Mar; 46(5):366-9. PubMed ID: 18785534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of extent of pancreatic and venous resection on survival for patients with pancreatic cancer.
    Serenari M; Ercolani G; Cucchetti A; Zanello M; Prosperi E; Fallani G; Masetti M; Lombardi R; Cescon M; Jovine E
    Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):389-394. PubMed ID: 31230959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility of resecting the portal vein only when necessary during pancreatoduodenectomy for pancreatic cancer.
    Kishi Y; Nara S; Esaki M; Hiraoka N; Shimada K
    BJS Open; 2019 Jun; 3(3):327-335. PubMed ID: 31183449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors after pancreatoduodenectomy with en bloc portal venous resection for pancreatic cancer.
    Lapshyn H; Bronsert P; Bolm L; Werner M; Hopt UT; Makowiec F; Wittel UA; Keck T; Wellner UF; Bausch D
    Langenbecks Arch Surg; 2016 Feb; 401(1):63-9. PubMed ID: 26739620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resection of portovenous structures to obtain microscopically negative margins during pancreaticoduodenectomy for pancreatic adenocarcinoma is worthwhile.
    Toomey P; Hernandez J; Morton C; Duce L; Farrior T; Villadolid D; Ross S; Rosemurgy A
    Am Surg; 2009 Sep; 75(9):804-9; discussion 809-10. PubMed ID: 19774952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reconsideration about the aggressive surgery for resectable pancreatic cancer: a focus on real pathological portosplenomesenteric venous invasion.
    Okabayashi T; Shima Y; Iwata J; Morita S; Sumiyoshi T; Kozuki A; Saisaka Y; Tokumaru T; Iiyama T; Noda Y; Hata Y; Matsumoto M
    Langenbecks Arch Surg; 2015 May; 400(4):487-94. PubMed ID: 25940756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Segmental portal/superior mesenteric vein resection and reconstruction with the iliac vein after pancreatoduodenectomy.
    Zhao X; Li LX; Fan H; Kou JT; Li XL; Lang R; He Q
    J Int Med Res; 2016 Dec; 44(6):1339-1348. PubMed ID: 28322103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse tumor biology associated with mesenterico-portal vein resection influences survival in patients with pancreatic ductal adenocarcinoma.
    Wang F; Gill AJ; Neale M; Puttaswamy V; Gananadha S; Pavlakis N; Clarke S; Hugh TJ; Samra JS
    Ann Surg Oncol; 2014 Jun; 21(6):1937-47. PubMed ID: 24558067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreatic neuroendocrine tumor: A multivariate analysis of factors influencing survival.
    Birnbaum DJ; Turrini O; Ewald J; Barbier L; Autret A; Hardwigsen J; Brunet C; Moutardier V; Le Treut YP; Delpero JR
    Eur J Surg Oncol; 2014 Nov; 40(11):1564-71. PubMed ID: 25086992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pancreatic adenocarcinoma: A simple CT score for predicting margin-positive resection in patients with resectable disease.
    Cassinotto C; Dohan A; Zogopoulos G; Chiche L; Laurent C; Sa-Cunha A; Cuggia A; Reinhold C; Gallix B
    Eur J Radiol; 2017 Oct; 95():33-38. PubMed ID: 28987689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.